Andreas Friedl

Statistics

Publications

Citations

314

H-Index

Active since

2001

Affiliations

Comprehensive Blood & Cancer Center(Current)

Andreas Friedl is an author at Comprehensive Blood & Cancer Center specializing in oncology, vascular endothelial growth factor, and vascular endothelial growth factor inhibitors.

Publications per year

2001–2003

Publications

Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

James P. Thomas, Rhoda Arzoomanian, Dona Alberti et al. · Journal of Clinical Oncology · 2003 · 226 citations

Medicine, Oncology, Pharmacology +16

Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin.

Christoph Mundhenke, James P. Thomas, George Wilding et al. · PubMed · 2001 · 88 citations

Medicine, Oncology, Pharmacology +13

1–2 of 2